Copper as an antibacterial agent for human pathogenic multidrug resistant Burkholderia cepacia complex bacteria

Journal of Bioscience and Bioengineering

Volumn 112, Issue 6, 2011, Pages 570-576

  Ibrahim, Muhammad ^a   Wang, Fang ^a   Lou, Miao miao ^a   Xie, Guan lin ^a   Li, Bin ^a   Bo, Zhu ^a   Zhang, Gou qing ^a   Liu, He ^a   Wareth, Abdul ^a  

^a ZHEJIANG UNIVERSITY   (China)

Author keywords

Antibacterial actvity; Burkholderia cepacia complex; Copper; Multidrug resistant; Opportunistic pathogen

Indexed keywords

ANTI-BACTERIAL ACTIVITY; ANTI-MICROBIAL AGENT; ANTIBACTERIAL ACTVITY; ANTIBACTERIAL AGENT; ANTIBACTERIAL EFFECTS; BACTERIAL CELLS; BACTERIAL COUNT; BACTERIAL INFECTIONS; BACTERIAL SPECIES; BACTERICIDAL ACTIVITY; BIOBURDEN; BURKHOLDERIA CEPACIA COMPLEX; CELLULAR STRUCTURE; COPPER IONS; COPPER SURFACE; HEALTHCARE FACILITY; INDUCTIVELY COUPLED PLASMA MASS SPECTROSCOPIES; INHIBITORY EFFECT; METALLIC COPPER; MULTIDRUG RESISTANT; SINGLE CELL GEL ELECTROPHORESIS; STAINING ASSAYS; ZONE OF INHIBITIONS;

ASSAYS; BACTERIA; BACTERICIDES; CELL DEATH; COPPER; COPPER POWDER; CRYSTAL STRUCTURE; ELECTROPHORESIS; HEALTH CARE; INDUCTIVELY COUPLED PLASMA; MASS SPECTROMETRY; METAL IONS; RATING; STAINLESS STEEL; VIRUSES;

COPPER COMPOUNDS;

ANTIBIOTIC AGENT; BACTERIAL DNA; COPPER; COPPER ION; POLYVINYLCHLORIDE; STAINLESS STEEL;

ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL CELL; BACTERIAL COUNT; BACTERIAL STRAIN; BACTERIAL SURVIVAL; BURKHOLDERIA; BURKHOLDERIA ARBORIS; BURKHOLDERIA CENOCEPACIA; BURKHOLDERIA CEPACIA; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA CONTAMINANS; BURKHOLDERIA DOLOSA; BURKHOLDERIA LATA; BURKHOLDERIA MULTIVORANS; BURKHOLDERIA SEMINALIS; BURKHOLDERIA VIETNAMIENSIS; CELL STRUCTURE; CONTROLLED STUDY; DNA DAMAGE; DRUG SCREENING; EXPOSURE; METAL METABOLISM; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; POWDER;

ANTI-BACTERIAL AGENTS; BURKHOLDERIA CEPACIA COMPLEX; BURKHOLDERIA INFECTIONS; COPPER; DNA DAMAGE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; HUMANS;

BACTERIA (MICROORGANISMS); BURKHOLDERIA CEPACIA COMPLEX;

EID: 83555178511     PISSN: 13891723     EISSN: 13474421     Source Type: Journal    
DOI: 10.1016/j.jbiosc.2011.08.017     Document Type: Article

References (44)

1. Vandamme P., Dawyndt P. Classification and identification of the Burkholderia cepacia complex: past, present and future. Syst. Appl. Microbiol. 2011, 34:87-95.
2. Chiarini L., Bevivino A., Dalmastri C., Tabacchioni S., Visca P. Burkholderia cepacia complex species: health hazards and biotechnological potential. Trends Microbiol. 2006, 14:277-286.
3. Vanlaere E., Lipuma J.J., Baldwin A., Henry D., De Brandt E., Mahenthiralingam E., Speert D., Dowson C., Vandamme P. Burkholderia latens sp. nov., Burkholderia diffusa sp. nov., Burkholderia arboris sp. nov., Burkholderia seminalis sp. nov. and Burkholderia metallica sp. nov., novel species within the Burkholderia cepacia complex. Int. J. Syst. Evol. Microbiol. 2008, 58:1580-1590.
4. Mahenthiralingam E., Urban T.A., Goldberg J.B. The multifarious, multireplicon Burkholderia cepacia complex. Nat. Rev. Microbiol. 2005, 3:144-156.
5. Drevinek P., Mahenthiralingam E. Burkholderia cenocepacia in cystic fibrosis: epidemiology and molecular mechanisms of virulence. Clin. Microbiol. Infect. 2010, 16:821-830.
6. Singhal L., Gautam V., Kaur M., Ray P. In vitro activity of doripenem against Burkholderia cepacia complex isolates from non-cystic fibrosis patients. Antimicrob. Agents Chemother. 2011, 55:1320-1321.
7. Govan J.R.W., Deretic V. Microbial pathogenesis in cystic fibrosis: mucoid Pseudomonas aeruginosa and Burkholderia cepacia. Microbiol. Rev. 1996, 60:539-574.
8. LiPuma J.J. Burkholderia cepacia: management issues and new insights. Clin. Chest. Med. 1998, 19:473-486.
9. Govan J.R., Brown P.H., Maddison J., Doherty C.J., Nelson J.W., Dodd M., Greening A.P., Webb A.K. Evidence for transmission of Pseudomonas cepacia by social contact in cystic fibrosis. Lancet 1993, 342:15-19.
10. Sajjan U.S., Sun L., Goldstein R., Forstner J.F. Cable (Cbl) type II pili of cystic fibrosis-associated Burkholderia (Pseudomonas) cepacia: nucleotide sequence of the cblA major subunit pilin gene and novel morphology of the assembled appendage fibers. J. Bacteriol. 1995, 177:1030-1038.
11. Mahenthiralingam E., Campbell M.E., Henry D.A., Speert D.P. Epidemiology of Burkholderia cepacia infection in patients with cystic fibrosis: analysis by random amplified polymorphic DNA (RAPD) fingerprinting. J. Clin. Microbiol. 1996, 34:2914-2920.
12. Mahenthiralingam E., Simpson D.A., Speert D.P. Identification and characterization of a novel DNA marker associated with epidemic strains of Burkholderia cepacia recovered from patients with cystic fibrosis. J. Clin. Microbiol. 1997, 35:808-816.
13. Hutchinson G.R., Parker S., Pryor J.A. Home-use nebulizers: a potential primary source of Burkholderia cepacia and other colistin-resistant, gram-negative bacteria in patients with cystic fibrosis. J. Clin. Microbiol. 1996, 34:584-587.
14. Høiby N. Isolation and treatment of cystic fibrosis patients with lung infections caused by Pseudomonas (Burkholderia) cepacia and multiresistant Pseudomonas aeruginosa. Neth. J. Med. 1995, 46:280-287.
15. Rose H., Baldwin A., Dowson C.G., Mahenthiralingam E. Biocide susceptibility of the Burkholderia cepacia complex. J. Antimicrob. Chemother. 2009, 63:502-510.
16. Pope C.E., Short P., Philip E., Carter P.E. Species distribution of Burkholderia cepacia complex isolates in cystic fibrosis and non-cystic fibrosis patients in New Zealand. J. Cyst. Fibros. 2010, 9:442-446.
17. Reik R., Spilker T., Lipuma J.J. Distribution of Burkholderia cepacia complex species among isolates recovered from persons with or without cystic fibrosis. J. Clin. Microbiol. 2005, 43:2926-2938.
18. Wenger P.N., Tokars J.I., Brennan P., Samel C., Bland L., Miller M., Carson L., Jarvis W. An outbreak of Enterobacter hormaechei infection and colonization in an intensive care nursery. Clin. Infect. Dis. 1997, 24:1243-1244.
19. Rensing C., Grass G. Escherichia coli mechanisms of copper homeostasis in a changing environment. FEMS Microbiol. 2003, 27:197-213.
20. Macomber L., Imlay J.A. The iron-sulfur clusters of dehydratases are primary intracellular targets of copper toxicity. Proc. Natl. Acad. Sci. 2009, 106:8344-8349.
21. Gordon A.S., Howell L.D., Harwood D. Responses of diverse heterotrophic bacteria to elevated copper concentrations. Can. J. Microbiol. 1994, 40:408-411.
22. Espirito Santo C., Morais P.V., Grass G. Isolation and characterization of bacteria resistant to metallic copper surfaces. Appl. Environ. Microbiol. 2010, 76:1341-1348.
23. Espirito Santo C., Lam E.W., Elowsky C.G., Quaranta D., Domaille D.W., Chang C.J., Grass G. Bacterial killing by dry metallic copper surfaces. Appl. Environ. Microbiol. 2011, 77:794-800.
24. Dollwet H.H., Sorenson J.R. Historic uses of copper compounds in medicine. Trace Elem. Med. 1985, 2:80-87.
25. Faundez G., Troncoso M., Navarrete P., Figueroa G. Antimicrobial activity of copper surfaces against suspensions of Salmonella enterica and Campylobacter jejuni. BMC Microbiol. 2004, 4:19.
26. Elguindi J., Wagner J., Rensing C. Genes involved in copper resistance influence survival of Pseudomonas aeruginosa on copper surfaces. J. Appl. Microbiol. 2009, 106:1448-1455.
27. Noyce J.O., Michels H., Keevil C.W. Potential use of copper surfaces to reduce survival of epidemic methicillin-resistant Staphylococcus aureus in the healthcare environment. J. Hosp. Infect. 2006, 63:289-297.
28. Borkow G., Gabbay J. Copper as a biocidal tool. Curr. Med. Chem. 2005, 12:2163-2175.
29. Grass G., Rensing C., Solioz M. Metallic copper as an antimicrobial surface. Appl. Environ. Microbiol. 2011, 77:1541-1547.
30. Sudha V.B.P., Singh K.O., Prasad S.R., Venkatasubramanian P. Killing of enteric bacteria in drinking water by a copper device for use in the home: laboratory evidence. Trans. R. Soc. Trop. Med. Hyg. 2009, 103:819-822.
31. Fang Y., Lou M.M., Li B., Xie G.L., Wang F., Zhang L.X., Luo Y.C. Characterization of Burkholderia cepacia complex from cystic fibrosis patients in China and their chitosan susceptibility. World J. Microbiol. Biotechnol. 2009, 26:4434-4450.
32. Fang Y., Xie G.L., Lou M.M., Li B., Ibrahim M. Diversity analysis of Burkholderia cepacia complex in the water bodies of West Lake, Hangzhou, China. J. Microbiol. 2010, 49:309-314.
33. Lou M., Fang Y., Zhang G., Xie G.L., Zhu B., Ibrahim M. Diversity of Burkholderia cepacia complex from the Moso Bamboo (Phyllostachys edulis) rhizhosphere soil. Curr. Microbiol. 2010, 62:650-658.
34. Li B., Fang Y., Zhang G.Q., Yu R.R., Lou M.M., Xie G.L., Wang Y.L., Sun G.C. Molecular characterization of Burkholderia cepacia complex isolates causing bacterial fruit rot of apricot. Plant Pathol. J. 2010, 26:223-230.
35. Mehtar S., Wiid I., Todorov S.D. The antimicrobial activity of copper and copper alloys against nosocomial pathogens and Mycobacterium tuberculosis isolated from healthcare facilities in the Western Cape: an in vitro study. J. Hosp. Infect. 2008, 68:45-51.
36. Fit N., Stefan R., Nadas G., Calina D. In vitro antibacterial activity of copper and bismuth powder. Bull. UASVM, Vet. Med. 2009, 66:297-301.
37. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L. A simple technique for quantitation of low levels of DNA damage in individual cells for DNA damage in individual cells. Exp. Cell Res. 1998, 175:184-191.
38. Briand G.G., Burford N. Bismuth compounds and preparations with biological or medicinal relevance. Chem. Rev. 1999, 99. 2601-265.
39. Cornick N.A., Silva M., Gorbach S.L. In vitro antibacterial activity of bismuth subsalicylate. Rev. Infect. Dis. 1990, 12:S9-S10.
40. Ohsumi Y., Kitamoto K., Anraku Y. Changes induced in the permeability barrier of the yeast plasma membrane by cupric ion. J. Bacteriol. 1998, 170:2676-2682.
41. Airey P., Verran J. Potential use of copper as a hygienic surface; problems associated with cumulative soiling and cleaning. J. Hosp. Infect. 2007, 67:272-278.
42. Casey A.L., Adams D., Karpanen T.J., Lambert P.A., Cookson B.D., Nightingale P., Miruszenko L., Shillam R., Christian P., Elliott T.S. Role of copper in reducing hospital environment contamination. J. Hosp. Infect. 2010, 74:72-77.
43. Holden M.T., Seth-Smith H.M., Crossman L.C., Sebaihia M., Bentley S.D., Cerdeño-Tárraga A.M., Thomson N.R., Bason N., Quail M.A., Sharp S., et al. The genome of Burkholderia cenocepacia J2315, an epidemic pathogen of cystic fibrosis patients. J. Bacteriol. 2009, 191:261-277.
44. Elguindi J., Wagner J., Rensing C. Genes involved in copper resistance influence survival of Pseudomonas aeruginosa on copper surfaces. J. Appl. Microbiol. 2009, 106:1448-1455.